Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

Systems biology in hepatology: approaches and applications.

Mardinoglu A, Boren J, Smith U, Uhlen M, Nielsen J.

Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):365-377. doi: 10.1038/s41575-018-0007-8. Review.

PMID:
29686404
2.

TP53INP2 regulates adiposity by activating β-catenin through autophagy-dependent sequestration of GSK3β.

Romero M, Sabaté-Pérez A, Francis VA, Castrillón-Rodriguez I, Díaz-Ramos Á, Sánchez-Feutrie M, Durán X, Palacín M, Moreno-Navarrete JM, Gustafson B, Hammarstedt A, Fernández-Real JM, Vendrell J, Smith U, Zorzano A.

Nat Cell Biol. 2018 Apr;20(4):443-454. doi: 10.1038/s41556-018-0072-9. Epub 2018 Mar 28.

PMID:
29593329
3.

Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.

Piening BD, Zhou W, Contrepois K, Röst H, Gu Urban GJ, Mishra T, Hanson BM, Bautista EJ, Leopold S, Yeh CY, Spakowicz D, Banerjee I, Chen C, Kukurba K, Perelman D, Craig C, Colbert E, Salins D, Rego S, Lee S, Zhang C, Wheeler J, Sailani MR, Liang L, Abbott C, Gerstein M, Mardinoglu A, Smith U, Rubin DL, Pitteri S, Sodergren E, McLaughlin TL, Weinstock GM, Snyder MP.

Cell Syst. 2018 Feb 28;6(2):157-170.e8. doi: 10.1016/j.cels.2017.12.013. Epub 2018 Jan 17.

PMID:
29361466
4.

CCN5/WISP2 and metabolic diseases.

Grünberg JR, Elvin J, Paul A, Hedjazifar S, Hammarstedt A, Smith U.

J Cell Commun Signal. 2018 Mar;12(1):309-318. doi: 10.1007/s12079-017-0437-z. Epub 2017 Dec 15. Review.

5.

Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes.

Mardinoglu A, Gogg S, Lotta LA, Stančáková A, Nerstedt A, Boren J, Blüher M, Ferrannini E, Langenberg C, Wareham NJ, Laakso M, Smith U.

EBioMedicine. 2018 Jan;27:151-155. doi: 10.1016/j.ebiom.2017.12.008. Epub 2017 Dec 7.

6.

Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.

Longo M, Raciti GA, Zatterale F, Parrillo L, Desiderio A, Spinelli R, Hammarstedt A, Hedjazifar S, Hoffmann JM, Nigro C, Mirra P, Fiory F, Formisano P, Miele C, Smith U, Beguinot F.

Diabetologia. 2018 Feb;61(2):369-380. doi: 10.1007/s00125-017-4471-4. Epub 2017 Oct 24.

PMID:
29067487
7.

Network analyses identify liver-specific targets for treating liver diseases.

Lee S, Zhang C, Liu Z, Klevstig M, Mukhopadhyay B, Bergentall M, Cinar R, Ståhlman M, Sikanic N, Park JK, Deshmukh S, Harzandi AM, Kuijpers T, Grøtli M, Elsässer SJ, Piening BD, Snyder M, Smith U, Nielsen J, Bäckhed F, Kunos G, Uhlen M, Boren J, Mardinoglu A.

Mol Syst Biol. 2017 Aug 21;13(8):938. doi: 10.15252/msb.20177703.

8.

BMP4 Gene Therapy in Mature Mice Reduces BAT Activation but Protects from Obesity by Browning Subcutaneous Adipose Tissue.

Hoffmann JM, Grünberg JR, Church C, Elias I, Palsdottir V, Jansson JO, Bosch F, Hammarstedt A, Hedjazifar S, Smith U.

Cell Rep. 2017 Aug 1;20(5):1038-1049. doi: 10.1016/j.celrep.2017.07.020.

9.

Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease.

Mardinoglu A, Stančáková A, Lotta LA, Kuusisto J, Boren J, Blüher M, Wareham NJ, Ferrannini E, Groop PH, Laakso M, Langenberg C, Smith U.

Cell Metab. 2017 Aug 1;26(2):281-283. doi: 10.1016/j.cmet.2017.07.006.

PMID:
28768165
10.

Increased adipose tissue aromatase activity improves insulin sensitivity and reduces adipose tissue inflammation in male mice.

Ohlsson C, Hammarstedt A, Vandenput L, Saarinen N, Ryberg H, Windahl SH, Farman HH, Jansson JO, Movérare-Skrtic S, Smith U, Zhang FP, Poutanen M, Hedjazifar S, Sjögren K.

Am J Physiol Endocrinol Metab. 2017 Oct 1;313(4):E450-E462. doi: 10.1152/ajpendo.00093.2017. Epub 2017 Jun 27.

PMID:
28655716
11.

A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.

Wood AR, Jonsson A, Jackson AU, Wang N, van Leewen N, Palmer ND, Kobes S, Deelen J, Boquete-Vilarino L, Paananen J, Stančáková A, Boomsma DI, de Geus EJC, Eekhoff EMW, Fritsche A, Kramer M, Nijpels G, Simonis-Bik A, van Haeften TW, Mahajan A, Boehnke M, Bergman RN, Tuomilehto J, Collins FS, Mohlke KL, Banasik K, Groves CJ, McCarthy MI; Diabetes Research on Patient Stratification (DIRECT), Pearson ER, Natali A, Mari A, Buchanan TA, Taylor KD, Xiang AH, Gjesing AP, Grarup N, Eiberg H, Pedersen O, Chen YD, Laakso M, Norris JM, Smith U, Wagenknecht LE, Baier L, Bowden DW, Hansen T, Walker M, Watanabe RM, 't Hart LM, Hanson RL, Frayling TM.

Diabetes. 2017 Aug;66(8):2296-2309. doi: 10.2337/db16-1452. Epub 2017 May 10.

12.

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology.

Westwood S, Liu B, Baird AL, Anand S, Nevado-Holgado AJ, Newby D, Pikkarainen M, Hallikainen M, Kuusisto J, Streffer JR, Novak G, Blennow K, Andreasson U, Zetterberg H, Smith U, Laakso M, Soininen H, Lovestone S.

Alzheimers Res Ther. 2017 Apr 26;9(1):31. doi: 10.1186/s13195-017-0258-6. Review.

13.

Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes.

Eliasson B, Rawshani A, Axelsen M, Hammarstedt A, Smith U.

PLoS One. 2017 Mar 13;12(3):e0173654. doi: 10.1371/journal.pone.0173654. eCollection 2017.

14.

Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.

Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, Ståhlman M, Adiels M, Hakkarainen A, Lundbom N, Kilicarslan M, Hallström BM, Lundbom J, Vergès B, Barrett PH, Watts GF, Serlie MJ, Nielsen J, Uhlén M, Smith U, Marschall HU, Taskinen MR, Boren J.

Mol Syst Biol. 2017 Mar 2;13(3):916. doi: 10.15252/msb.20167422.

15.

Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance.

Grünberg JR, Hoffmann JM, Hedjazifar S, Nerstedt A, Jenndahl L, Elvin J, Castellot J, Wei L, Movérare-Skrtic S, Ohlsson C, Holm LM, Bäckhed F, Syed I, Bosch F, Saghatelian A, Kahn BB, Hammarstedt A, Smith U.

Sci Rep. 2017 Feb 27;7:43515. doi: 10.1038/srep43515.

16.

12th Key Symposium Introduction: insulin resistance in common diseases.

Smith U.

J Intern Med. 2016 Nov;280(5):426-429. doi: 10.1111/joim.12561. No abstract available.

PMID:
27762486
17.

Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.

Smith U, Kahn BB.

J Intern Med. 2016 Nov;280(5):465-475. doi: 10.1111/joim.12540. Epub 2016 Oct 3. Review.

18.

Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial.

van Raalte DH, Bunck MC, Smits MM, Hoekstra T, Cornér A, Diamant M, Eliasson B, Marja-RiittaTaskinen, Heine RJ, Smith U, HanneleYki-Järvinen, Mari A.

Eur J Endocrinol. 2016 Oct;175(4):345-52. doi: 10.1530/EJE-16-0286. Epub 2016 Jul 27.

19.

Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.

Walford GA, Gustafsson S, Rybin D, Stančáková A, Chen H, Liu CT, Hong J, Jensen RA, Rice K, Morris AP, Mägi R, Tönjes A, Prokopenko I, Kleber ME, Delgado G, Silbernagel G, Jackson AU, Appel EV, Grarup N, Lewis JP, Montasser ME, Landenvall C, Staiger H, Luan J, Frayling TM, Weedon MN, Xie W, Morcillo S, Martínez-Larrad MT, Biggs ML, Chen YD, Corbaton-Anchuelo A, Færch K, Gómez-Zumaquero JM, Goodarzi MO, Kizer JR, Koistinen HA, Leong A, Lind L, Lindgren C, Machicao F, Manning AK, Martín-Núñez GM, Rojo-Martínez G, Rotter JI, Siscovick DS, Zmuda JM, Zhang Z, Serrano-Rios M, Smith U, Soriguer F, Hansen T, Jørgensen TJ, Linnenberg A, Pedersen O, Walker M, Langenberg C, Scott RA, Wareham NJ, Fritsche A, Häring HU, Stefan N, Groop L, O'Connell JR, Boehnke M, Bergman RN, Collins FS, Mohlke KL, Tuomilehto J, März W, Kovacs P, Stumvoll M, Psaty BM, Kuusisto J, Laakso M, Meigs JB, Dupuis J, Ingelsson E, Florez JC.

Diabetes. 2016 Oct;65(10):3200-11. doi: 10.2337/db16-0199. Epub 2016 Jul 14.

20.

Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance.

Lee S, Zhang C, Kilicarslan M, Piening BD, Bjornson E, Hallström BM, Groen AK, Ferrannini E, Laakso M, Snyder M, Blüher M, Uhlen M, Nielsen J, Smith U, Serlie MJ, Boren J, Mardinoglu A.

Cell Metab. 2016 Jul 12;24(1):172-84. doi: 10.1016/j.cmet.2016.05.026. Epub 2016 Jun 23.

21.

High plasma osteocalcin is associated with low blood haemoglobin in elderly men: the MrOS Sweden Study.

Lewerin C, Johansson H, Karlsson MK, Lorentzon M, Lerner UH, Kindblom JM, Ohlsson C, Smith U, Mellström D.

J Intern Med. 2016 Oct;280(4):398-406. doi: 10.1111/joim.12505. Epub 2016 Apr 1.

PMID:
27038007
22.

A LC-MS-based workflow for measurement of branched fatty acid esters of hydroxy fatty acids.

Zhang T, Chen S, Syed I, Ståhlman M, Kolar MJ, Homan EA, Chu Q, Smith U, Borén J, Kahn BB, Saghatelian A.

Nat Protoc. 2016 Apr;11(4):747-63. doi: 10.1038/nprot.2016.040. Epub 2016 Mar 17.

23.

Is leptin coming back? A short introduction to the presentations in this symposium session at the 2015 annual meeting of the EASD.

Smith U.

Diabetologia. 2016 May;59(5):918-9. doi: 10.1007/s00125-016-3894-7. Epub 2016 Mar 4. No abstract available.

PMID:
26943812
24.

Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.

Mardinoglu A, Boren J, Smith U.

Cell Metab. 2016 Jan 12;23(1):10-2. doi: 10.1016/j.cmet.2015.12.012.

25.

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels.

Smits MM, Bunck MC, Diamant M, Corner A, Eliasson B, Heine RJ, Smith U, Yki-Järvinen H, van Raalte DH.

Diabetes Care. 2016 Mar;39(3):e42-3. doi: 10.2337/dc15-2489. Epub 2015 Dec 30. No abstract available.

PMID:
26721816
26.

Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients.

Eliasson B, Smith U, Mullen S, Cushman SW, Sherman AS, Yang J.

Adipocyte. 2014 Dec 10;3(4):314-21. doi: 10.4161/adip.34425. eCollection 2014 Oct-Dec.

27.

Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk.

Gustafson B, Smith U.

Atherosclerosis. 2015 Jul;241(1):27-35. doi: 10.1016/j.atherosclerosis.2015.04.812. Epub 2015 Apr 30. Review.

PMID:
25957567
28.

Abdominal obesity: a marker of ectopic fat accumulation.

Smith U.

J Clin Invest. 2015 May;125(5):1790-2. doi: 10.1172/JCI81507. Epub 2015 May 1. Review.

29.

Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.

Amrutkar M, Cansby E, Chursa U, Nuñez-Durán E, Chanclón B, Ståhlman M, Fridén V, Mannerås-Holm L, Wickman A, Smith U, Bäckhed F, Borén J, Howell BW, Mahlapuu M.

Diabetes. 2015 Aug;64(8):2791-804. doi: 10.2337/db15-0060. Epub 2015 Apr 6.

30.

Insulin resistance and impaired adipogenesis.

Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U.

Trends Endocrinol Metab. 2015 Apr;26(4):193-200. doi: 10.1016/j.tem.2015.01.006. Epub 2015 Feb 18. Review.

PMID:
25703677
31.

Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.

Amrutkar M, Cansby E, Nuñez-Durán E, Pirazzi C, Ståhlman M, Stenfeldt E, Smith U, Borén J, Mahlapuu M.

FASEB J. 2015 Apr;29(4):1564-76. doi: 10.1096/fj.14-264937. Epub 2015 Jan 21.

PMID:
25609431
32.

BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis.

Gustafson B, Hammarstedt A, Hedjazifar S, Hoffmann JM, Svensson PA, Grimsby J, Rondinone C, Smith U.

Diabetes. 2015 May;64(5):1670-81. doi: 10.2337/db14-1127. Epub 2015 Jan 20.

33.

High serum adiponectin is associated with low blood haemoglobin in elderly men: the Swedish MrOS study.

Lewerin C, Johansson H, Lerner UH, Karlsson MK, Lorentzon M, Barrett-Connor E, Smith U, Ohlsson C, Mellström D.

J Intern Med. 2015 Jul;278(1):68-76. doi: 10.1111/joim.12340. Epub 2015 Feb 10.

34.

Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.

Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, Patel RT, Lee J, Chen S, Peroni OD, Dhaneshwar AS, Hammarstedt A, Smith U, McGraw TE, Saghatelian A, Kahn BB.

Cell. 2014 Oct 9;159(2):318-32. doi: 10.1016/j.cell.2014.09.035.

35.

Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage?

Cederberg H, Stančáková A, Kuusisto J, Laakso M, Smith U.

J Intern Med. 2015 May;277(5):540-51. doi: 10.1111/joim.12289. Epub 2014 Aug 1.

36.

Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained.

Cansby E, Nerstedt A, Amrutkar M, Durán EN, Smith U, Mahlapuu M.

Mol Cell Endocrinol. 2014 Aug 5;393(1-2):143-51. doi: 10.1016/j.mce.2014.06.014. Epub 2014 Jun 26.

PMID:
24976178
37.

Advanced glycation end products, dementia, and diabetes.

Lovestone S, Smith U.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4743-4. doi: 10.1073/pnas.1402277111. Epub 2014 Mar 25. No abstract available.

38.

The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT.

Grünberg JR, Hammarstedt A, Hedjazifar S, Smith U.

J Biol Chem. 2014 Mar 7;289(10):6899-907. doi: 10.1074/jbc.M113.511964. Epub 2014 Jan 22.

39.

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes.

Van Raalte DH, van Genugten RE, Eliasson B, Möller-Goede DL, Mari A, Tura A, Wilson C, Fleck P, Taskinen MR, Smith U, Diamant M.

Eur J Endocrinol. 2014 Mar 8;170(4):565-74. doi: 10.1530/EJE-13-0639. Print 2014 Apr.

40.

Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.

Dimas AS, Lagou V, Barker A, Knowles JW, Mägi R, Hivert MF, Benazzo A, Rybin D, Jackson AU, Stringham HM, Song C, Fischer-Rosinsky A, Boesgaard TW, Grarup N, Abbasi FA, Assimes TL, Hao K, Yang X, Lecoeur C, Barroso I, Bonnycastle LL, Böttcher Y, Bumpstead S, Chines PS, Erdos MR, Graessler J, Kovacs P, Morken MA, Narisu N, Payne F, Stancakova A, Swift AJ, Tönjes A, Bornstein SR, Cauchi S, Froguel P, Meyre D, Schwarz PE, Häring HU, Smith U, Boehnke M, Bergman RN, Collins FS, Mohlke KL, Tuomilehto J, Quertemous T, Lind L, Hansen T, Pedersen O, Walker M, Pfeiffer AF, Spranger J, Stumvoll M, Meigs JB, Wareham NJ, Kuusisto J, Laakso M, Langenberg C, Dupuis J, Watanabe RM, Florez JC, Ingelsson E, McCarthy MI, Prokopenko I; MAGIC Investigators.

Diabetes. 2014 Jun;63(6):2158-71. doi: 10.2337/db13-0949. Epub 2013 Dec 2. Review.

41.

Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4.

Gustafson B, Hammarstedt A, Hedjazifar S, Smith U.

Diabetes. 2013 Sep;62(9):2997-3004. doi: 10.2337/db13-0473. No abstract available.

42.

A standardized vascular disease health check in europe: a cost-effectiveness analysis.

Schuetz CA, Alperin P, Guda S, van Herick A, Cariou B, Eddy D, Gumprecht J, Nicolucci A, Schwarz P, Wareham NJ, Witte DR, Smith U.

PLoS One. 2013 Jul 15;8(7):e66454. doi: 10.1371/journal.pone.0066454. Print 2013.

43.

Non-cholesterol sterol levels predict hyperglycemia and conversion to type 2 diabetes in Finnish men.

Cederberg H, Gylling H, Miettinen TA, Paananen J, Vangipurapu J, Pihlajamäki J, Kuulasmaa T, Stančáková A, Smith U, Kuusisto J, Laakso M.

PLoS One. 2013 Jun 28;8(6):e67406. doi: 10.1371/journal.pone.0067406. Print 2013.

44.

Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes.

Yaghootkar H, Lamina C, Scott RA, Dastani Z, Hivert MF, Warren LL, Stancáková A, Buxbaum SG, Lyytikäinen LP, Henneman P, Wu Y, Cheung CY, Pankow JS, Jackson AU, Gustafsson S, Zhao JH, Ballantyne CM, Xie W, Bergman RN, Boehnke M, el Bouazzaoui F, Collins FS, Dunn SH, Dupuis J, Forouhi NG, Gillson C, Hattersley AT, Hong J, Kähönen M, Kuusisto J, Kedenko L, Kronenberg F, Doria A, Assimes TL, Ferrannini E, Hansen T, Hao K, Häring H, Knowles JW, Lindgren CM, Nolan JJ, Paananen J, Pedersen O, Quertermous T, Smith U; GENESIS Consortium; RISC Consortium, Lehtimäki T, Liu CT, Loos RJ, McCarthy MI, Morris AD, Vasan RS, Spector TD, Teslovich TM, Tuomilehto J, van Dijk KW, Viikari JS, Zhu N, Langenberg C, Ingelsson E, Semple RK, Sinaiko AR, Palmer CN, Walker M, Lam KS, Paulweber B, Mohlke KL, van Duijn C, Raitakari OT, Bidulescu A, Wareham NJ, Laakso M, Waterworth DM, Lawlor DA, Meigs JB, Richards JB, Frayling TM.

Diabetes. 2013 Oct;62(10):3589-98. doi: 10.2337/db13-0128. Epub 2013 Jul 8. Review.

45.

Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high-fat diet.

Cansby E, Amrutkar M, Mannerås Holm L, Nerstedt A, Reyahi A, Stenfeldt E, Borén J, Carlsson P, Smith U, Zierath JR, Mahlapuu M.

FASEB J. 2013 Sep;27(9):3660-71. doi: 10.1096/fj.13-228494. Epub 2013 May 31.

PMID:
23729594
46.

Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes.

Nerstedt A, Cansby E, Amrutkar M, Smith U, Mahlapuu M.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):68-78. doi: 10.1016/j.mce.2013.05.013. Epub 2013 May 21.

PMID:
23707791
47.

Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes.

Xie W, Wood AR, Lyssenko V, Weedon MN, Knowles JW, Alkayyali S, Assimes TL, Quertermous T, Abbasi F, Paananen J, Häring H, Hansen T, Pedersen O, Smith U, Laakso M; MAGIC Investigators; DIAGRAM Consortium; GENESIS Consortium; RISC Consortium, Dekker JM, Nolan JJ, Groop L, Ferrannini E, Adam KP, Gall WE, Frayling TM, Walker M.

Diabetes. 2013 Jun;62(6):2141-50. doi: 10.2337/db12-0876. Epub 2013 Feb 1.

48.

WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4.

Hammarstedt A, Hedjazifar S, Jenndahl L, Gogg S, Grünberg J, Gustafson B, Klimcakova E, Stich V, Langin D, Laakso M, Smith U.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2563-8. doi: 10.1073/pnas.1211255110. Epub 2013 Jan 28.

49.

Geometric morphometric character suites as phylogenetic data: extracting phylogenetic signal from gastropod shells.

Smith UE, Hendricks JR.

Syst Biol. 2013 May 1;62(3):366-85. doi: 10.1093/sysbio/syt002. Epub 2013 Jan 16.

PMID:
23325808
50.

A new paradigm for improved co-ordination and efficacy of European biomedical research: taking diabetes as a model.

Halban PA, Boulton AJ, Smith U.

Diabetologia. 2013 Mar;56(3):439-43. doi: 10.1007/s00125-012-2790-z. Epub 2012 Dec 13.

PMID:
23238786

Supplemental Content

Support Center